These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21098796)

  • 1. In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.
    Milak MS; DeLorenzo C; Zanderigo F; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2010 Dec; 51(12):1892-900. PubMed ID: 21098796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
    Milak MS; Severance AJ; Ogden RT; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2008 Apr; 49(4):587-96. PubMed ID: 18344443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.
    Milak MS; Severance AJ; Prabhakaran J; Kumar JS; Majo VJ; Ogden RT; Mann JJ; Parsey RV
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):243-9. PubMed ID: 20571518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.
    Kumar JS; Prabhakaran J; Majo VJ; Milak MS; Hsiung SC; Tamir H; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1050-60. PubMed ID: 17221184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.
    Majo VJ; Milak MS; Prabhakaran J; Mali P; Savenkova L; Simpson NR; Mann JJ; Parsey RV; Kumar JS
    Bioorg Med Chem; 2013 Sep; 21(17):5598-604. PubMed ID: 23816046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
    Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
    J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.
    Giovacchini G; Conant S; Herscovitch P; Theodore WH
    J Nucl Med; 2009 Nov; 50(11):1794-800. PubMed ID: 19837769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain.
    Shrestha SS; Liow JS; Lu S; Jenko K; Gladding RL; Svenningsson P; Morse CL; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2014 Jan; 55(1):141-6. PubMed ID: 24385311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.
    Hines CS; Liow JS; Zanotti-Fregonara P; Hirvonen J; Morse C; Pike VW; Innis RB
    PLoS One; 2011; 6(9):e25309. PubMed ID: 21980419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
    Kumar JS; Majo VJ; Hsiung SC; Millak MS; Liu KP; Tamir H; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    J Med Chem; 2006 Jan; 49(1):125-34. PubMed ID: 16392798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT1A Receptor PET Radioligand 11C-CUMI-101 Has Significant Binding to α1-Adrenoceptors in Human Cerebellum, Limiting Its Use as a Reference Region.
    Shrestha SS; Liow JS; Jenko K; Ikawa M; Zoghbi SS; Innis RB
    J Nucl Med; 2016 Dec; 57(12):1945-1948. PubMed ID: 27587705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of high and low affinity serotonin 1A receptors by PET in vivo in nonhuman primates.
    Kumar JS; Milak MS; Majo VJ; Prabhakaran J; Mali P; Savenkova L; Mann JJ; Parsey RV
    J Pharmacol Sci; 2012; 120(3):254-7. PubMed ID: 23076129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
    McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.
    Parsey RV; Slifstein M; Hwang DR; Abi-Dargham A; Simpson N; Mawlawi O; Guo NN; Van Heertum R; Mann JJ; Laruelle M
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1111-33. PubMed ID: 10908045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study.
    Frey BN; Rosa-Neto P; Lubarsky S; Diksic M
    Neuroimage; 2008 Aug; 42(2):850-7. PubMed ID: 18583156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.
    Talbot PS; Slifstein M; Hwang DR; Huang Y; Scher E; Abi-Dargham A; Laruelle M
    Neuroimage; 2012 Jan; 59(1):271-85. PubMed ID: 21782029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling.
    Hahn A; Nics L; Baldinger P; Ungersböck J; Dolliner P; Frey R; Birkfellner W; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Neuroimage; 2012 Aug; 62(1):199-206. PubMed ID: 22579604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.